Slim Now TN’s public offer makes the monthly numbers easier to find than the agreement behind them. The practice advertises semaglutide and tirzepatide, an office in Murfreesboro and telehealth visits within Tennessee. It also publishes separate price tables for the two medicines. Yet a general $195 first-month promotion sits alongside an $85 initial semaglutide listing, without an explanation of which price governs. For someone considering enrollment, that discrepancy is not merely a comparison-shopping issue: it affects what the first payment is supposed to purchase.
This documentary review examines the public pages consulted October 19, 2026, with a focus on enrollment obligations and service responsibilities. The central distinction is between a posted monthly price and a documented monthly agreement. Slim Now TN describes consultations, follow-up and medication for administration at home, but the consulted material does not settle renewal authorization, cancellation, refunds or the identity of the dispensing pharmacy. Those gaps do not establish unfavorable terms; they mean the public offer is not sufficient to reconstruct the full agreement.
At a glance
- Documented program
- Slim Now TN advertises semaglutide and tirzepatide, a Murfreesboro office and telehealth visits in Tennessee.Sources: [3]
- First-payment discrepancy
- A general first-month offer is $195, while the semaglutide table lists 0.25 mg at $85 per month with an initial consultation.Sources: [3]
- Published monthly tiers
- Semaglutide listings range from $85 to $300 per month; tirzepatide listings range from $195 to $495 per month. Prices correspond to different listed presentations.Sources: [3]
- Initial service
- Initial options describe a consultation, medication-use instructions and a first administration in the office; the remote-care alternative is not explained.Sources: [3]
- Agreement boundaries
- The consulted pages do not establish automatic renewal, minimum commitment, cancellation, refund or prepayment terms.Sources: [3]
Start with the agreement, not the headline price
Slim Now TN’s general offer says, “For the first month we offer this program for $195,” followed by a subsequent payment schedule. Separately, its semaglutide table lists 0.25 mg at $85 per month and includes an initial provider consultation. The tirzepatide table lists 2.5 mg at $195 per month, also including an initial consultation. Nothing in the consulted wording expressly reconciles the general promotion with the lower semaglutide entry. Neither number should be silently substituted for the other.
Before paying, a prospective patient should request a written statement naming the selected medicine, its exact formulation and presentation, the first charge and the services that charge covers. Ask whether the $195 statement applies to that particular option and whether any quoted amount supersedes the website. This is especially important because the practice explicitly says the price increases if the patient chooses a dosage increase. That statement describes a pricing condition, not instructions to change treatment.
The public material does not establish whether payment occurs when booking, after consultation or when medication is arranged. Nor does it explain the financial outcome if a consultation does not lead to a prescription. A useful starting point is the distinction outlined in our guide to enrollment terms worth checking: agreeing to an appointment, authorizing treatment and authorizing future charges can be separate decisions. Slim Now TN’s public pages do not map those decisions.
| Listed presentation | Semaglutide monthly price | Tirzepatide monthly price |
|---|---|---|
| Initial listed tier | 0.25 mg: $85; initial consultation included | 2.5 mg: $195; initial consultation included |
| Next listed tier | 0.50 mg: $125 | 5 mg: $295 |
| Next listed tier | 1 mg: $200 | 7.5 mg: $395 |
| Next listed tier | 1.50 mg: $250 | 10 mg: $495 |
| Additional semaglutide tier | 2 mg: $300 | No additional tier documented in the consulted table |
What the monthly tables promise—and leave open
Beyond the initial entries, semaglutide is advertised at $125 per month for 0.50 mg, $200 for 1 mg, $250 for 1.50 mg and $300 for 2 mg. Tirzepatide is advertised at $295 per month for 5 mg, $395 for 7.5 mg and $495 for 10 mg. These are distinct commercial listings, not a schedule a reader should follow. The higher-tier entries describe a monthly provider checkup and measurement of progress and vital signs.
The tables also describe medication for administration at home. However, the listed milligram amounts do not by themselves establish the container, concentration, total quantity dispensed or exact formulation. The general explanation describes injections under the skin, without naming a commercial product. A written quote should connect the amount charged to the precise product and quantity being provided, rather than leaving the patient to infer supply from a price-card label.
The words “per Month” and “/mo” identify the advertised pricing period, but do not establish the charge date or refill interval. The pages do not clarify laboratory coverage, taxes, additional fees, insurance acceptance or insurer reimbursement. They also do not establish whether a separately scheduled visit would cost extra. Our guide to monthly billing and commitments explains the broader distinction: a monthly price is not, by itself, proof of either a cancel-anytime arrangement or a minimum term.
Cancellation and refunds remain undocumented
The consulted pages do not publish a minimum commitment, automatic-renewal provision, cancellation method or notice deadline. They also do not establish prepayment requirements or discounts. It would therefore be inaccurate to describe Slim Now TN as either a subscription service or a no-commitment program. The practical question is what the office asks a patient to authorize during enrollment, including any payment authorization that is not reproduced on the public website.
Ask for the actual cancellation instructions before authorizing recurring charges, if recurring charges are proposed. The instructions should identify who receives notice, how receipt is confirmed and which future services or orders the notice stops. Our discussion of cancellation notice and order status is useful preparation, but it cannot supply terms missing from this provider’s documentation. No particular notice period, renewal date or processing cutoff can be attributed to Slim Now TN from these pages.
Refunds are a separate unresolved issue. The public material does not say whether consultation charges, unused medication or orders already placed are refundable. It also does not describe what happens financially after a clinical decision to change or discontinue treatment. A cancellation request should not be treated as an automatic refund request, and neither should be assumed to succeed under undocumented terms. The useful next step is a written explanation tied to each component of the quoted payment.
Enrollment has a local-office step that telehealth does not explain
Slim Now TN directs prospective patients to contact the office for a consultation with a provider. It publishes 615-439-6929 and info@slimnowtn.com, and also offers an appointment-request form. These are documented contact paths, not promises about appointment availability or response speed. The public material does not describe the full GLP-1 evaluation process, including age requirements, medical screening, required laboratory work or the circumstances in which the practice would decline to prescribe.
The initial options include medication-use instructions and say the first dose is administered in the office. At the same time, the practice advertises telehealth visits in Tennessee. The pages do not explain whether remote patients must travel for that first administration, whether an alternative arrangement exists or whether telehealth is intended mainly for follow-up. That uncertainty matters to someone outside Murfreesboro who is evaluating the program as a remote service.
Before scheduling, ask which parts of enrollment require physical attendance and whether the consultation fee changes if the appointment is remote. Also ask when any required test results must be available and who pays for them. Those questions clarify the transaction without assuming clinical eligibility. A consultation is an opportunity for assessment; the published invitation to schedule does not amount to a guaranteed prescription or confirmation that a particular medicine will be appropriate.
Identify the product and pharmacy before accepting fulfillment terms
The website names semaglutide and tirzepatide, but the consulted documentation does not identify brands, manufacturers or the dispensing pharmacy. A “Pharmacy Partner” link appears, yet its destination content was not available in the reviewed material. Consequently, this review cannot determine whether the specific products offered are commercially manufactured or compounded, or establish their regulatory status. Naming an ingredient does not settle those questions, and FDA approval cannot be attributed to a clinic.
FDA explains that compounded preparations are not FDA approved and do not undergo its premarket review for safety, effectiveness and quality. Nonapproval alone does not establish clinical inequivalence. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. This is general regulatory context, not evidence that Slim Now TN supplies compounded preparations or that any particular pharmacy meets those conditions.
Medication described as being administered at home is not necessarily medication shipped to the home. Slim Now TN’s pages do not settle pickup versus shipment, delivery charges, temperature handling or arrival timing. Ask who handles dispensing questions, an incorrect order or a delayed delivery; our guide to clinician and pharmacy responsibilities provides a useful framework. If an injectable GLP-1 product arrives warm or insufficiently refrigerated, FDA explicitly advises not using it and contacting the provider or dispensing pharmacy.
Follow-up is described, but responsibility between visits is not
The higher-tier price cards provide a concrete service description: a monthly checkup with a provider, plus measurement of progress and vital signs. That is more informative than a medication-only price, but it does not establish appointment length, remote monitoring methods or the scope of additional care. The public material also does not specify how patients reach the clinical team between appointments, how quickly treatment questions receive answers or whether support is available outside office hours.
The practice lists Madison Umbeck as FNP-C, MSCP and describes her as a board-certified family nurse practitioner. It attributes her nursing bachelor’s degree to Saint Louis University and nursing master’s degree to Belmont University. It identifies owner J. Seth Weathersby as PA-C, with an exercise-science bachelor’s degree and a Master’s of Medicine from Trevecca Nazarene University. These are provider-published professional biographies, not independent license or credential verification.
The site also says Weathersby serves on Tennessee’s physician-assistant board and has more than 20 years of urgent-care experience. Shelby Turvey is listed as FNP-C with more than 30 years in healthcare. These descriptions should not be rewritten as physician credentials or a guarantee of who handles a particular appointment. Ask which clinician manages ongoing care, who provides coverage during absences and whether additional clinical contacts carry separate charges.
Office access, website privacy and optional services
The published office address is 5607 Franklin Rd, Murfreesboro, TN 37128. Listed hours are Monday through Thursday, 8 a.m. to 5 p.m.; Friday, 8 a.m. to noon; and every other Saturday, 9 a.m. to 2 p.m. The alternating Saturday schedule warrants confirmation when booking. Telehealth availability is explicitly described for Tennessee; the consulted material does not establish service in other states or a separate after-hours contact pathway.
The privacy policy discusses website comments: it says comment submissions collect form data, IP addresses and browser information for spam detection, and retain comments and metadata indefinitely. It permits requests to erase personal data, subject to administrative, legal and security retention exceptions. Those statements do not establish clinical-record retention periods or explain telehealth data handling. The consulted material did not include the HIPAA link’s content, and generic website account language does not demonstrate a clinical patient portal.
Slim Now TN also advertises NAD+, including a 50 mg listing at $50 per month. That is a separate commercial offering, not a documented GLP-1 inclusion. Its NAD+ section names pregnancy or breastfeeding, active cancer, severe liver or renal failure and known NAD+ allergies as reasons not to take that service. Those statements must not be repurposed as Slim Now TN’s GLP-1 eligibility policy. Ask that any optional service appear separately on the quote.
Keep financial consent separate from treatment expectations
A clear agreement would make Slim Now TN easier to evaluate, but it would not establish clinical results. The practice’s promotional weight-loss language is not a measured outcome for its patients. Without product identification and provider-specific outcome documentation, this review cannot connect the advertised service to a particular expected result. The published price tiers likewise do not demonstrate which treatment is suitable for an individual or how long that person would remain in care.
NIDDK advises discussing benefits, side effects, health conditions, other medicines, family history and costs with a clinician. Follow-up concerns response and tolerability, not simply renewed payments. Treatment duration depends on response and adverse effects, and obesity may require long-term care. For enrollment purposes, that makes two separate questions essential: what clinical follow-up is planned, and what financial obligations apply if that plan changes. Neither answer should be inferred from a monthly price card.
Questions & answers
Is Slim Now TN’s first month $85 or $195?
Both amounts appear in different places. The general program offer says $195 for the first month, while the initial semaglutide listing says $85 per month for 0.25 mg with a consultation. Initial tirzepatide is listed at $195 per month for 2.5 mg. The public wording does not reconcile the discrepancy. Request a written, option-specific first-payment quote.
Can I cancel after one month?
The consulted pages do not establish that right or a longer minimum commitment. They also do not publish automatic-renewal, notice or refund terms. Ask for the enrollment agreement and payment authorization before paying. Specifically confirm how cancellation affects future appointments, future charges and any medication order already placed; these may involve different decisions.
Can Tennessee telehealth patients complete everything remotely?
That is not established. Slim Now TN advertises Tennessee telehealth visits, but its initial options also describe a first administration in the office. Ask whether an in-person visit is required, where it occurs and what remote follow-up involves. The pages do not confirm availability outside Tennessee or explain an alternative first-administration process for remote patients.
Which pharmacy and exact products does Slim Now TN use?
The consulted documentation does not identify the dispensing pharmacy, brands, manufacturers or exact formulations. It therefore does not establish whether the products are compounded or commercially manufactured. Ask for that information before accepting fulfillment terms, including the label details and a pharmacy contact. This review cannot assign regulatory status from ingredient names alone.
What is included besides medication?
Initial listings describe a consultation, use instructions and first administration in the office. Higher-tier listings describe monthly provider checkups and measurement of progress and vital signs. Medication for home administration is also described. Laboratory coverage, extra visits, taxes, shipment and other possible charges are not resolved in the consulted pages, so request an itemized quote rather than assuming an all-inclusive fee.
How do I contact the practice before enrolling?
The published phone number is 615-439-6929, and the email address is info@slimnowtn.com. The website also provides an appointment-request form. The office is at 5607 Franklin Rd in Murfreesboro. These channels are useful for requesting written pricing and enrollment documents, but the pages do not promise a response time or identify an out-of-hours clinical support service.
Our assessment
Slim Now TN provides useful building blocks for comparison: a physical Tennessee office, named clinical staff, two advertised medicines, specific monthly price tiers and descriptions of initial and follow-up services. Its principal documentary weakness is that those building blocks do not form a complete enrollment agreement. The first-month discrepancy is unresolved, product and pharmacy identities are missing, and public cancellation and refund boundaries are not established. That does not prove the eventual agreement is unfavorable, but it prevents a confident account of what a patient would authorize. Before payment, the most useful documents would be an option-specific written quote, the actual payment and cancellation terms, confirmation of the product and dispensing pharmacy, and an explanation of the in-office requirement for telehealth patients. If the office supplies clear answers, readers can evaluate the concrete offer rather than relying on assumptions about a monthly price.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.